Brauer M, Günther A, Pleul K, Götze M, Wachsmuth C, Meinig T, Bauer M, Witte O W, Rahmel A
Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Jena, Am Klinikum 1, 07747, Jena, Deutschland.
Hans-Berger-Klinik für Neurologie, Universitätsklinikum Jena, Jena, Deutschland.
Anaesthesist. 2019 Jan;68(1):22-29. doi: 10.1007/s00101-018-0510-x. Epub 2018 Nov 16.
No systematic study has previously been undertaken in Germany to ascertain why irreversible brain death determination (BDD) has not been carried out.
A comprehensive analysis of reasons for unperformed BDD in deceased patients with acute, severe brain damage could improve the identification of potential organ donors.
Using the Transplantcheck program of the German Organ Transplantation Foundation (DSO) an analysis of the data from 2016 was undertaken in participating hospitals in Saxony, Saxony-Anhalt and Thuringia (Region East of the DSO), regarding why a BDD was not initiated in deceased patients with primary or secondary brain damage.
In 128 of the 144 Region East hospitals, 7889 deceased patients with primary or secondary brain damage were detected. In 7389 patients a BDD was out of the question for a variety of reasons. In 232 patients organ donation was not considered due to an advance directive. In 195 cases treatment was limited based on the patient's infaust neurological prognosis without the possibility of organ donation being discussed with relatives. In 73 cases initiation of BDD was indicated but not performed.
The number of potential organ donors in Region East of the DSO could be significantly increased by identifying patients where BDD is indicated. By consistent evaluation of patients' wills in terms of organ donation before treatment is withdrawn in patients with poor neurological prognosis, additional potential organ donors could be identified. Furthermore, involving neurointensive care physicians in the care of all patients with brain damage could improve the prognostic assessment.
德国此前尚未进行过系统研究以确定为何未开展不可逆脑死亡判定(BDD)。
对急性重症脑损伤死亡患者未进行BDD的原因进行全面分析,可能会改善潜在器官捐献者的识别。
利用德国器官移植基金会(DSO)的Transplantcheck程序,对萨克森、萨克森 - 安哈尔特和图林根(DSO东部地区)参与研究的医院2016年的数据进行分析,了解原发性或继发性脑损伤死亡患者未启动BDD的原因。
在144家东部地区医院中的128家,检测到7889例原发性或继发性脑损伤死亡患者。在7389例患者中,由于各种原因无法进行BDD。在232例患者中,因生前预嘱未考虑器官捐献。在195例病例中,基于患者不良的神经学预后限制了治疗,未与亲属讨论器官捐献的可能性。在73例病例中,虽表明应启动BDD但未实施。
通过识别应进行BDD的患者,DSO东部地区潜在器官捐献者的数量可能会显著增加。对于神经学预后不良的患者,在撤掉治疗前就器官捐献问题对患者意愿进行统一评估,可能会识别出更多潜在器官捐献者。此外,让神经重症监护医生参与所有脑损伤患者的护理,可能会改善预后评估。